These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38027656)

  • 1. Nitazoxanide and quercetin co-loaded nanotransfersomal gel for topical treatment of cutaneous leishmaniasis with macrophage targeting and enhanced anti-leishmanial effect.
    Bashir S; Shabbir K; Din FU; Khan SU; Ali Z; Khan BA; Kim DW; Khan GM
    Heliyon; 2023 Nov; 9(11):e21939. PubMed ID: 38027656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage targeting of nitazoxanide-loaded transethosomal gel in cutaneous leishmaniasis.
    Khalid H; Batool S; Din FU; Khan S; Khan GM
    R Soc Open Sci; 2022 Oct; 9(10):220428. PubMed ID: 36249328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antileishmanial Agents Co-loaded in Transfersomes with Enhanced Macrophage Uptake and Reduced Toxicity.
    Zahid F; Batool S; Ud-Din F; Ali Z; Nabi M; Khan S; Salman O; Khan GM
    AAPS PharmSciTech; 2022 Aug; 23(6):226. PubMed ID: 35970966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell.
    Dar MJ; Din FU; Khan GM
    Drug Deliv; 2018 Nov; 25(1):1595-1606. PubMed ID: 30105918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-delivery of amphotericin B and pentamidine loaded niosomal gel for the treatment of
    Anjum A; Shabbir K; Din FU; Shafique S; Zaidi SS; Almari AH; Alqahtani T; Maryiam A; Moneeb Khan M; Al Fatease A; Bashir S; Khan GM
    Drug Deliv; 2023 Dec; 30(1):2173335. PubMed ID: 36722301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage targeting with the novel carbopol-based miltefosine-loaded transfersomal gel for the treatment of cutaneous leishmaniasis:
    Batool S; Zahid F; Ud-Din F; Naz SS; Dar MJ; Khan MW; Zeb A; Khan GM
    Drug Dev Ind Pharm; 2021 Mar; 47(3):440-453. PubMed ID: 33615936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and evaluation of novel miltefosine-polyphenol co-loaded second generation nano-transfersomes for the topical treatment of cutaneous leishmaniasis.
    Dar MJ; McElroy CA; Khan MI; Satoskar AR; Khan GM
    Expert Opin Drug Deliv; 2020 Jan; 17(1):97-110. PubMed ID: 31786952
    [No Abstract]   [Full Text] [Related]  

  • 8. Development, in vitro and in vivo evaluation of miltefosine loaded nanostructured lipid carriers for the treatment of Cutaneous Leishmaniasis.
    Khan AS; Ud Din F; Ali Z; Bibi M; Zahid F; Zeb A; Mujeeb-Ur-Rehman ; Khan GM
    Int J Pharm; 2021 Jan; 593():120109. PubMed ID: 33253802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical treatment of cutaneous leishmaniasis with novel amphotericin B-miltefosine co-incorporated second generation ultra-deformable liposomes.
    Dar MJ; Khalid S; McElroy CA; Satoskar AR; Khan GM
    Int J Pharm; 2020 Jan; 573():118900. PubMed ID: 31765786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-Delivery Anticancer Drug Nanoparticles for Synergistic Therapy Against Lung Cancer Cells.
    Shen Y; TanTai J
    Drug Des Devel Ther; 2020; 14():4503-4510. PubMed ID: 33122893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannosylated imiquimod-terbinafine co-loaded transethosomes for cutaneous leishmaniasis; assessment of its anti-leishmanial potential, in vivo safety and immune response modulation.
    Jamshaid H; Din FU; Nousheen K; Khan SU; Fatima A; Khan S; Choi HG; Khan GM
    Biomater Adv; 2023 Feb; 145():213266. PubMed ID: 36577194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Designing, Optimization and Characterization of Trifluralin Transfersomal Gel to Passively Target Cutaneous Leishmaniasis.
    Khan AU; Jamshaid H; Ud Din F; Zeb A; Khan GM
    J Pharm Sci; 2022 Jun; 111(6):1798-1811. PubMed ID: 35081406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation and statistical optimization of letrozole loaded nanotransferosomal gel for tumor targeting.
    Imtiaz S; Sohail S; Din FU; Ali Z; Batool S; Malik M; Nawaz A; Alamri AH; Lahiq AA; Alsharif ST; Asiri A
    Pharm Dev Technol; 2024 Sep; 29(7):703-718. PubMed ID: 39023747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction.
    Natesan S; Pandian S; Ponnusamy C; Palanichamy R; Muthusamy S; Kandasamy R
    Int J Biol Macromol; 2017 Nov; 104(Pt B):1837-1845. PubMed ID: 28472691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifampicin-loaded nanotransferosomal gel for treatment of cutaneous leishmaniasis: passive targeting via topical route.
    Rabia S; Khaleeq N; Batool S; Dar MJ; Kim DW; Din FU; Khan GM
    Nanomedicine (Lond); 2020 Jan; 15(2):183-203. PubMed ID: 31916472
    [No Abstract]   [Full Text] [Related]  

  • 16. Preparation and characterization of artemether-loaded niosomes in Leishmania major-induced cutaneous leishmaniasis.
    Niroumand U; Motazedian MH; Ahmadi F; Asgari Q; Bahreini MS; Ghasemiyeh P; Mohammadi-Samani S
    Sci Rep; 2024 May; 14(1):10073. PubMed ID: 38698123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant free synthesis of cationic nano-vesicles: A safe triple drug loaded vehicle for the topical treatment of cutaneous leishmaniasis.
    Khalid S; Salman S; Iqbal K; Rehman FU; Ullah I; Satoskar AR; Khan GM; Dar MJ
    Nanomedicine; 2022 Feb; 40():102490. PubMed ID: 34748957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Concanavalin-A conjugated nanotransfersomal gel of apigenin for enhanced targeted delivery of UV induced skin malignant melanoma.
    Jangdey MS; Kaur CD; Saraf S
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):904-916. PubMed ID: 30856018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser-responsive liposome for selective tumor targeting of nitazoxanide nanoparticles.
    Darwish WM; Bayoumi NA; El-Kolaly MT
    Eur J Pharm Sci; 2018 Jan; 111():526-533. PubMed ID: 29097304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid nanocarrier of selegiline augmented anti-Parkinson's effect via P-gp modulation using quercetin.
    Qamar Z; Ashhar MU; Annu ; Qizilibash FF; Sahoo PK; Ali A; Ali J; Baboota S
    Int J Pharm; 2021 Nov; 609():121131. PubMed ID: 34563617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.